Literature DB >> 27160690

Evaluation of Urinary Indices for Albuminuria and Proteinuria in Patients with Chronic Kidney Disease.

Dennis Sung Chul Hong1, Il Hwan Oh, Joon-Sung Park, Chang Hwa Lee, Chong Myung Kang, Gheun-Ho Kim.   

Abstract

BACKGROUND/AIMS: Either protein-to-creatinine ratio (PCR) or albumin-to-creatinine ratio (ACR) can be adopted for estimation of proteinuria in patients with chronic kidney disease (CKD). Estimated protein excretion rate (ePER) and estimated albumin excretion rate (eAER) may be superior to ACR and PCR. Reports show that urine albumin-to-protein ratio (APR) may be useful in detecting tubular proteinuria, but should be compared with urine protein electrophoresis (PEP).
METHODS: Both 24-h urine and spot urine were collected from 77 stable CKD patients for measurement of albumin, protein, and creatinine, and PEP. Based on MDRD and CKD-EPI equations, ePERMDRD, ePERCKD-EPI, eAERMDRD and eAERCKD-EPI were calculated to estimate daily proteinuria and albuminuria. Glomerular CKD was defined by clinical and/or pathological evidence.
RESULTS: ACR correlated significantly with PCR. However, microalbuminuria was present in patients without pathologic proteinuria. Twenty-four-hour urine albumin correlated better with eAERMDRD and eAERCKD-EPI than ACR, and 24-h urine protein correlated better with ePERMDRD and ePERCKD-EPI than PCR. APR significantly but not well correlated with the albumin fraction in urine PEP. The albumin fraction obtained from urine PEP was significantly higher in patients with glomerulopathy than those with non-glomerular CKD, whereas there were no differences in APR between groups. In contrast with APR, the albumin fraction in urine PEP was independently associated with glomerular CKD.
CONCLUSIONS: Both PCR and ACR are useful in evaluation of proteinuria. In quantifying daily proteinuria and albuminuria, ePER and eAER are superior to PCR and ACR, respectively. Compared with APR, urine PEP is more useful in diagnosing glomerular proteinuria.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27160690     DOI: 10.1159/000443429

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

1.  Kidney Disease: Personalized Lifestyle Health Care Makes a Big Difference.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-12

Review 2.  Recent advances in nephropathy biomarker detections using paper-based analytical devices.

Authors:  Akhmad Sabarudin; Setyawan P Sakti; Hani Susianti; Nur Samsu; Ika O Wulandari; Yudit Oktanella; Dewi Anggraeni
Journal:  Anal Sci       Date:  2022-02-28       Impact factor: 2.081

3.  Urinary Dipstick Is Not Reliable as a Screening Tool for Albuminuria in the Emergency Department-A Prospective Cohort Study.

Authors:  Christian B Nielsen; Henrik Birn; Frans Brandt; Jan D Kampmann
Journal:  Diagnostics (Basel)       Date:  2022-02-10

4.  Utilizing Estimated Creatinine Excretion to Improve the Performance of Spot Urine Samples for the Determination of Proteinuria in Kidney Transplant Recipients.

Authors:  Michael Ke Wang; Christine White; Ayub Akbari; Pierre Brown; Naser Hussain; Swapnil Hiremath; Greg Knoll
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

5.  Correlation between Serum Uric Acid Level and Microalbuminuria in Type-2 Diabetic Nephropathy.

Authors:  Hina Latif; Adil Iqbal; Rabia Rathore; Nasir Farooq Butt
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

6.  Microalbuminuria as a simple predictor of incident diabetes over 8 years in the Korean Genome and Epidemiology Study (KoGES).

Authors:  Dong-Hyuk Jung; Young-Sup Byun; Yu-Jin Kwon; Gwang-Sil Kim
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

7.  Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children.

Authors:  Ben Christopher Reynolds; Jennifer Lynn Roem; Derek Kai Sing Ng; Mina Matsuda-Abedini; Joseph Thomas Flynn; Susan Lynn Furth; Bradley Alan Warady; Rulan Savita Parekh
Journal:  JAMA Netw Open       Date:  2020-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.